Medical Device Risk Classification
The system by which regulatory authorities categorize medical devices based on their potential risk to patients and users. Risk classification determines the regulatory pathway, level of scrutiny, and documentation requirements for market approval.
Medical device risk classification is the regulatory mechanism that assigns devices to risk categories based on factors such as duration of contact with the body, degree of invasiveness, whether the device is active (uses an energy source), and the body part it interacts with. Higher-risk classifications trigger more stringent regulatory requirements.
Classification systems by market
Different markets use different classification systems, though they share common principles. The EU uses four classes (I, IIa, IIb, III) under MDR Annex VIII rules. The FDA uses three classes (I, II, III) based on product codes. Japan uses four classes (I-IV). Australia aligns with the GHTF framework (Class I, IIa, IIb, III). China's NMPA uses three classes (I, II, III). Understanding classification across markets is essential for multi-market regulatory strategy.
Classification and procurement
A device's risk class directly affects tender compliance requirements. Higher-class devices require more extensive documentation — clinical evaluation reports, Notified Body certificates, PMA approvals — than lower-class devices. Procurement teams use classification to determine which regulatory evidence to request and verify during tender evaluation.